Navigation Links
ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
Date:6/20/2012

CONSHOHOCKEN, Pa., June 20, 2012 /PRNewswire/ -- ePharmaSolutions announces the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK.

ePharmaSolutions, a leading clinical services and technology solutions provider has acquired Polaris BioPharma Consulting to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies. This acquisition increases ePharmaSolutions' global bandwidth while expanding its core workforce with a team of experienced patient recruitment specialists in every major continent who can implement global projects at the local level.

"We have worked closely with Polaris over the last ten years on some very complex projects, and they have always delivered," stated Lance Converse, ePharmaSolutions' Founder and CEO.   "They have a wealth of knowledge of the regulatory, clinical and cultural landscape, from a local perspective, and have connections with varied regional referral sources to expedite study enrollment. This addition is integral to the company's continued growth."

Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.  Over the last 13 years, Polaris has grown to 20 local recruitment specialists in every continent providing in-country support on global recruitment campaigns.

"We are proud to be a part of ePharmaSolutions and committed to our collective mission to improve and accelerate clinical trials through empirical expertise in patient recruitment, compliance and retention," stated Sanjiv Kanwar, Polaris Biopharma's Managing Director.   "We can now fully leverage the data-driven technology assets ePharmaSolutions has developed with Polaris' global experience and regionally based recruitment specialists to provide Sponsors with high-impact, results-driven site feasibility and patient recruitment campaigns."

ePharmaSolutions and Polaris will be attending the Annual DIA Meeting in Philadelphia June 25th – 28th 2012 at booth 1427.

About ePharmaSolutions
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.  ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 260,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit www.epharmasolutions.com or email info@epharmasolutions.com

About Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm with over 20 regionally based recruitment specialists spanning each continent.   Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.  Polaris is headquartered in Slough, UK.   For more information visit www.polarisbpc.com or email info@polarisbpc.com


'/>"/>
SOURCE ePharmaSolutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
2. S.E.D. Labs to be Acquired by Quest Diagnostics
3. Celtaxsys Acquires Clinical Stage Innate Immunity Drug for Inflammation
4. TrovaGene Acquires CLIA - Certified Laboratory
5. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
8. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Amgen to Acquire Micromet
11. Camelot Healthcare Training Institute Acquired by Medtech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):